Evidence map›Paper›PMID 24598459›Full record

Observational studyJournal of the International AIDS Society2014

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.

Sasisopin Kiertiburanakul, David Boettiger, Man Po Lee, Sharifah Fs Omar, Junko Tanuma, Oon Tek Ng, Nicolas Durier, Praphan Phanuphak, Rossana Ditangco, Romanee Chaiwarith and 16 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Temporal trends in tuberculosis and time from enrolment in care to antiretroviral therapy initiation: A multicountry cohort study from Latin America.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Determinants of Late HIV Presentation at Ndlavela Health Center in Mozambique.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sasisopin KiertiburanakulFaculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; sasisopin.kie@mahidol.ac.th.
David BoettigerThe Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Man Po LeeQueen Elizabeth Hospital, Hong Kong, China SAR.
Sharifah Fs OmarUniversity of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Junko TanumaNational Center for Global Health and Medicine, Toyama Shinjuku-ku, Tokyo, Japan.
Oon Tek NgTan Tock Seng Hospital, Singapore.
Nicolas DurierTREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Praphan PhanuphakHIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Rossana DitangcoResearch Institute for Tropical Medicine, Manila, Philippines.
Romanee ChaiwarithResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Pacharee KantipongChiang Rai Prachanukroh Hospital, Chiang Rai, Thailand.
Christopher Kc LeeHospital Sungai Buloh, Sungai Buloh, Malaysia.
Mahiran MustafaHospital Raja Perempuan Zainab II, Kota Bharu, Malaysia.
Vonthanak SaphonnNational Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
Winai RatanasuwanFaculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Tuti Parwati MeratiFaculty of Medicine, Udayana University & Sanglah Hospital, Bali, Indonesia.
Nagalingeswaran KumarasamyYRG Centre for AIDS Research and Education, Chennai, India.
Wing Wai WongTaipei Veterans General Hospital and AIDS Prevention and Research Centre, National Yang-Ming University, Taipei, Taiwan.
Fujie ZhangBeijing Ditan Hospital, Beijing, China.
Thanh Thuy PhamBach Mai Hospital, Hanoi, Vietnam.
Sanjay PujariInstitute of Infectious Diseases, Pune, India.
Jun Yong ChoiDivision of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Evy YunihastutiWorking Group on AIDS Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Somnuek SungkanuparphFaculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
TREAT Asia HIV Observational Databases (TAHOD)
TREAT Asia Studies to Evaluate Resistance (TASER)

Funding

The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
NIAID NIH HHS U01 AI069907NIAID NIH HHS U01AI069907
6 · The paper itself

Abstract

introductionAlthough antiretroviral therapy (ART) has been rapidly scaled up in Asia, most HIV-positive patients in the region still present with late-stage HIV disease. We aimed to determine trends of pre-ART CD4 levels over time in Asian HIV-positive patients and to determine factors associated with late ART initiation.

methodsData from two regional cohort observational databases were analyzed for trends in median CD4 cell counts at ART initiation and the proportion of late ART initiation (CD4 cell counts <200 cells/mm(3) or prior AIDS diagnosis). Predictors for late ART initiation and mortality were determined.

resultsA total of 2737 HIV-positive ART-naïve patients from 22 sites in 13 Asian countries and territories were eligible. The overall median (IQR) CD4 cell count at ART initiation was 150 (46-241) cells/mm(3). Median CD4 cell counts at ART initiation increased over time, from a low point of 115 cells/mm(3) in 2008 to a peak of 302 cells/mm(3) after 2011 (p for trend 0.002). The proportion of patients with late ART initiation significantly decreased over time from 79.1% before 2007 to 36.3% after 2011 (p for trend <0.001). Factors associated with late ART initiation were year of ART initiation (e.g. 2010 vs. before 2007; OR 0.40, 95% CI 0.27-0.59; p<0.001), sex (male vs. female; OR 1.51, 95% CI 1.18-1.93; p=0.001) and HIV exposure risk (heterosexual vs. homosexual; OR 1.66, 95% CI 1.24-2.23; p=0.001 and intravenous drug use vs. homosexual; OR 3.03, 95% CI 1.77-5.21; p<0.001). Factors associated with mortality after ART initiation were late ART initiation (HR 2.13, 95% CI 1.19-3.79; p=0.010), sex (male vs. female; HR 2.12, 95% CI 1.31-3.43; p=0.002), age (≥51 vs. ≤30 years; HR 3.91, 95% CI 2.18-7.04; p<0.001) and hepatitis C serostatus (positive vs. negative; HR 2.48, 95% CI 1.-4.36; p=0.035).

conclusionsMedian CD4 cell count at ART initiation among Asian patients significantly increases over time but the proportion of patients with late ART initiation is still significant. ART initiation at higher CD4 cell counts remains a challenge. Strategic interventions to increase earlier diagnosis of HIV infection and prompt more rapid linkage to ART must be implemented.

Indexed as

AdultAnti-HIV AgentsAsiaCD4 Lymphocyte CountDelayed DiagnosisFemaleHIV InfectionsHumansMaleMiddle AgedProspective StudiesTime FactorsAnti-HIV AgentsAIDSantiretroviral therapyAsiaCD4HIVtrends

Identifiers

PMID24598459
PMCPMC3944639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.